Biodistribution, pharmacokinetics, and blood compatibility of native and PEGylated tobacco mosaic virus nano-rods and -spheres in mice
about
Fluorescent Tobacco mosaic virus-Derived Bio-Nanoparticles for Intravital Two-Photon Imaging.Stealth filaments: Polymer chain length and conformation affect the in vivo fate of PEGylated potato virus X.Interface of physics and biology: engineering virus-based nanoparticles for biophotonicsVirus-Based Nanoparticles as Versatile NanomachinesVirus-based nanomaterials as positron emission tomography and magnetic resonance contrast agents: from technology development to translational medicineSize Dependent Cellular Uptake of Rod-like Bionanoparticles with Different Aspect Ratios.Influence of surfactant and lipid type on the physicochemical properties and biocompatibility of solid lipid nanoparticles.Dual-modal magnetic resonance and fluorescence imaging of atherosclerotic plaques in vivo using VCAM-1 targeted tobacco mosaic virusNanoassembly routes stimulate conflicting antibody quantity and quality for transmission-blocking malaria vaccines.High Aspect Ratio Nanotubes Formed by Tobacco Mosaic Virus for Delivery of Photodynamic Agents Targeting Melanoma.POxylation as an alternative stealth coating for biomedical applications.Nanomanufacturing of Tobacco Mosaic Virus-Based Spherical Biomaterials Using a Continuous Flow Method.The Protein Corona of Plant Virus Nanoparticles Influences their Dispersion Properties, Cellular Interactions, and In Vivo Fates.To Target or Not to Target: Active vs. Passive Tumor Homing of Filamentous Nanoparticles Based on Potato virus XShaping bio-inspired nanotechnologies to target thrombosis for dual optical-magnetic resonance imaging.The Impact of Aspect Ratio on the Biodistribution and Tumor Homing of Rigid Soft-Matter NanorodsDesign of virus-based nanomaterials for medicine, biotechnology, and energy.Serum albumin 'camouflage' of plant virus based nanoparticles prevents their antibody recognition and enhances pharmacokinetics.Tobacco Mosaic Virus Delivery of Phenanthriplatin for Cancer therapy.Tobacco mosaic virus-based protein nanoparticles and nanorods for chemotherapy delivery targeting breast cancer.Virus-based scaffolds for tissue engineering applications.Nanobiotechnology for the Therapeutic Targeting of Cancer Cells in Blood.Synthetic multivalency for biological applications.Combination of Plant Virus Nanoparticle-Based in Situ Vaccination with Chemotherapy Potentiates Antitumor Response.Viruses, Artificial Viruses and Virus-Based Structures for Biomedical Applications.Plant viruses and bacteriophages for drug delivery in medicine and biotechnology.Enhancing Antibody Response against Small Molecular Hapten with Tobacco Mosaic Virus as a Polyvalent Carrier.Polymer Structure and Conformation Alter the Antigenicity of Virus-like Particle-Polymer Conjugates.Synthetic plant virology for nanobiotechnology and nanomedicinePlant viral and bacteriophage delivery of nucleic acid therapeutics.Elongated plant virus-based nanoparticles for enhanced delivery of thrombolytic therapies.Biodistribution and toxicity evaluation of sesbania mosaic virus nanoparticles in mice.Plant virus incorporated hydrogels as scaffolds for tissue engineering possess low immunogenicity in vivo.Meeting report VLPNPV: Session 5: Plant based technology.Virus-like nanoparticles: emerging tools for targeted cancer diagnostics and therapeutics.Thermal conversion of filamentous potato virus X into spherical particles with different properties from virions.Shape induced acid responsive heat triggered highly facilitated drug release by cube shaped magnetite nanoparticles.Repurposing Plant Virus Nanoparticles.Current Progress of Virus-mimicking Nanocarriers for Drug DeliveryTechnoeconomic Modeling of Plant-Based Griffithsin Manufacturing
P2860
Q27307604-6F240054-C82B-458E-8EB8-0AB175419384Q27334548-573C3E98-EDCA-4AA4-8FC3-3DD09130FFC5Q27339766-56E6D61D-B9C9-4A5B-8BEF-CE251428DA11Q28068538-041CCC6C-77E7-4952-B787-C0C11974C2E9Q28550482-E27C9F8C-8564-4B72-B80C-A8EDD5BE73B4Q30385575-F8135F89-022C-4E97-948A-97A3C8026FD9Q30432397-12E54B1B-95F9-4B25-8439-6C233225A83AQ30587267-81312575-E927-4A6B-B94E-DE050CAB9CB1Q33812439-F8E360C6-3808-4151-B257-7268ACFA9DAFQ33902315-9D67197D-813B-4FD6-86F1-7AE6CD916DFBQ33903653-087E493D-B5B9-4EFF-82C3-FDE45BBF1CD8Q35589913-74AEB873-939F-42F3-B286-DDBAA0CC3AE6Q35917005-6446AEB2-F957-4E94-B1E1-9124C9564CD5Q35967955-1C20863A-2AEC-4CAD-8572-86CB7DAB9ADFQ36204756-C3E5F643-0F0E-45F3-B861-CBF046EBABA0Q37068238-3E8C23A7-DE4F-445D-A50C-40D1970DFCC5Q37346447-E5FC56A5-6E40-4703-BA83-4569C762F97AQ37451428-4B1F6D7B-A494-43F7-B5D7-89A4C43FB21FQ37500884-9BE64C38-FF63-44E4-80F0-969723F8888AQ37551457-2880E9E4-4280-4E98-8CC2-C4A07EE3B2F3Q38293045-933FABC0-538D-4A2B-9A77-590958DAE5EDQ38387142-14790D28-39B4-473C-94FB-9060A7CDFF06Q38598783-EFFC09BA-26A6-4776-80F7-359EFBE1C35BQ38708960-C4E08BD3-11FA-4A5A-B6D3-72C549C1F027Q38818912-ED6C3C92-F280-4010-ABBF-730C2F316D1AQ38828420-E18A22C7-B1C5-4AA2-9AD0-CB7EC59E6A1EQ38882114-7B7231C5-744E-45D5-BAAD-EA8071B84B28Q39000229-AAD0D29D-ACF1-4C79-9C4E-00581F2F41A5Q39081725-8C7ECC8F-4568-42B2-B779-5BE0085CD765Q39441748-566172EE-FBFA-4CA1-8120-3595D0C0DF37Q40053619-49273D5B-1370-4732-85E1-B90BB7C57EA0Q40659970-3F9B6C04-8086-455C-9D57-2A51BC2E5862Q42218738-170A1A04-D6D4-4801-9B50-39DFEF6C7475Q42346870-97E53173-5E9A-4B8B-B312-C5A87F71B6FAQ45324998-58C1C013-9E8B-45C0-B7BA-3188AB5E718AQ45336783-3AD59C3E-295E-46F0-9E3B-E5EDC38D0A42Q45956701-4774DE10-B774-4342-8C0C-994BF5C9EDE1Q50002181-D1F0A50A-E79E-41DD-9145-CFEE35009CB1Q56513874-25B44176-05E4-4277-96BA-6900BCCE8AF8Q56975148-18917EE6-428F-4D35-BC90-A5C3C6659047
P2860
Biodistribution, pharmacokinetics, and blood compatibility of native and PEGylated tobacco mosaic virus nano-rods and -spheres in mice
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Biodistribution, pharmacokinet ...... nano-rods and -spheres in mice
@en
Biodistribution, pharmacokinet ...... ano-rods and -spheres in mice.
@nl
type
label
Biodistribution, pharmacokinet ...... nano-rods and -spheres in mice
@en
Biodistribution, pharmacokinet ...... ano-rods and -spheres in mice.
@nl
prefLabel
Biodistribution, pharmacokinet ...... nano-rods and -spheres in mice
@en
Biodistribution, pharmacokinet ...... ano-rods and -spheres in mice.
@nl
P2093
P2860
P1433
P1476
Biodistribution, pharmacokinet ...... nano-rods and -spheres in mice
@en
P2093
Allen VanMeter
Andrew J Shoffstall
Lauren N Randolph
Nicole F Steinmetz
Rebecca E Taurog
Stephen Hern
P2860
P304
P356
10.1016/J.VIROL.2013.10.035
P407
P577
2013-12-05T00:00:00Z